SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006765
Filing Date
2021-05-11
Accepted
2021-05-11 08:34:46
Documents
64
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgtx-20210331x10q.htm   iXBRL 10-Q 1696389
2 EX-31.1 mgtx-20210331xex31d1.htm EX-31.1 11369
3 EX-31.2 mgtx-20210331xex31d2.htm EX-31.2 11319
4 EX-32.1 mgtx-20210331xex32d1.htm EX-32.1 6760
5 EX-32.2 mgtx-20210331xex32d2.htm EX-32.2 6768
  Complete submission text file 0001558370-21-006765.txt   6276751

Data Files

Seq Description Document Type Size
6 EX-101.SCH mgtx-20210331.xsd EX-101.SCH 49550
7 EX-101.CAL mgtx-20210331_cal.xml EX-101.CAL 55262
8 EX-101.DEF mgtx-20210331_def.xml EX-101.DEF 140851
9 EX-101.LAB mgtx-20210331_lab.xml EX-101.LAB 372064
10 EX-101.PRE mgtx-20210331_pre.xml EX-101.PRE 320432
11 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20210331x10q_htm.xml XML 992151
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38520 | Film No.: 21909763
SIC: 2836 Biological Products, (No Diagnostic Substances)